Novel Isolate of Halobacteriovorax Capable of Killing Multi-Drug-Resistant Escherichia coli and Salmonella

<b>Background/Objectives:</b> Due to the rising problem of antimicrobial resistance, there is increasing attention in the scientific community towards alternative approaches to combat Antimicrobial-Resistant (AMR) pathogens that do not involve the use of antibiotics. In this regard, the European Medicines Agency (EMA) and the European Food Safety Authority (EFSA) have promoted experimentation with predatory bacteria to fight antibiotic resistance. With the aim of identifying predatory bacteria suitable for the control of antibiotic-resistant bacteria, in this work we isolated a strain of <i>Halobacteriovorax</i> from an estuarine aquatic environment using a CTX-M-producing <i>E. coli</i> strain as prey and characterized it with respect to optimal physico-chemical parameters for growth and predation. Furthermore, we studied its predatory capacity against other <i>E. coli</i> strains and Multi-Drug-Resistant (MDR) <i>Salmonella</i>. Finally, we conducted challenge experiments to evaluate the growth of predator and prey over time. <b>Methods:</b> The <i>Halobacteriovorax</i> strain, designated HE7, was identified by 16S rRNA analysis. To isolate <i>Halobacteriovorax</i> and to evaluate its predatory ability towards different preys, the double-layer agar plating technique was applied. <b>Results:</b> HE7 showed in vitro predatory activity against all MDR strains of <i>E. coli</i> and <i>Salmonella</i> tested. In the 10⁷ predator/10³ prey and 10⁷ predator/10⁷ prey challenges, HE7 after 6 h achieved the total killing and a reduction of about 6 logs in the prey, respectively, maintaining this effect for up to 24 h. <b>Conclusions:</b> The results of this study highlight that HE7, but more generally <i>Halobacteriovorax</i>, could find application both alone and in an integrated context of antimicrobial strategies as an alternative to antibiotics.